Skip to main content
Erschienen in: World Journal of Surgery 12/2008

01.12.2008

Risk Factors for Lateral Cervical Lymph Node Involvement in Follicular Thyroid Carcinoma

verfasst von: Haitham Alfalah, Isaac Cranshaw, Thomas Jany, Laurent Arnalsteen, Emmanuelle Leteurtre, Catherine Cardot, François Pattou, Bruno Carnaille

Erschienen in: World Journal of Surgery | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Metastases from follicular thyroid carcinoma (FTC) are usually blood borne and far less to lymph nodes (LN). The present study was designed to evaluate the factors that are associated with LN metastases in patients operated on for FTC.

Methods

A retrospective review of 70 patients (25 men; mean age, 47 (range, 14–92) years) operated on between January 1995 and December 2005 for FTC was undertaken. All patients had histopathology study of the regional LN and postoperative radioiodine scintigraphy. According to LN invasion, they were divided into two groups in which various parameters were compared.

Results

The length of follow-up was 52 (range 17–108) months. A total of 375 LN were examined from ipsilateral neck side and 87 LN from the contralateral side. LN metastases were found in five (7%) cases: all ipsilateral. Comparing data from the patients with and without LN metastases, respectively, age was 60 and 47 years (p = 0.12), male/female ratio was 1/4 and 24/41 (p = 0.44), tumor size was 68 and 37 mm (p < 0.01), tumor differentiation (well/moderate) was 3/2 and 25/19 (p = 0.89), distant metastases were detected in 1 and 8 cases (p = 0.72) .The tumor size was >40 mm in 35 (50%) patients. All patients with LN metastases were found in this group (5/35; 14%).

Conclusions

Follicular thyroid carcinoma results in metastases to regional lymph nodes in 7% of cases but only to the ipsilateral neck side. Tumor size is the only factor that impacts it. We do not recommend lymph node dissection in follicular thyroid carcinomas <4 cm.
Literatur
1.
Zurück zum Zitat Zeiger MA, Dackiw AP (2005) Follicular thyroid lesions, elements that affect both diagnosis and prognosis. J Surg Oncol 89:108–113PubMedCrossRef Zeiger MA, Dackiw AP (2005) Follicular thyroid lesions, elements that affect both diagnosis and prognosis. J Surg Oncol 89:108–113PubMedCrossRef
2.
Zurück zum Zitat Rosai J (2004) Thyroid gland. Rosai and Ackerman’s surgical pathology, 9th edn. Mosby Inc., New York, pp 542–544 Rosai J (2004) Thyroid gland. Rosai and Ackerman’s surgical pathology, 9th edn. Mosby Inc., New York, pp 542–544
3.
Zurück zum Zitat Lo CY, Chan WF, Lam KY et al (2005) Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 242:708–715PubMedCrossRef Lo CY, Chan WF, Lam KY et al (2005) Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 242:708–715PubMedCrossRef
4.
Zurück zum Zitat Burgess JR, Dwyer T, McArdle K et al (2000) The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978–1998) during a transition from iodine sufficiency to iodine deficiency. J Clin Endocrinol Metab 85(4):1513–1517PubMedCrossRef Burgess JR, Dwyer T, McArdle K et al (2000) The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978–1998) during a transition from iodine sufficiency to iodine deficiency. J Clin Endocrinol Metab 85(4):1513–1517PubMedCrossRef
5.
Zurück zum Zitat Fioretti F, Tavani A, Gallus S et al (1999) Case-control study of thyroid cancer in Northern Italy: attributable risk. Int J Epidemiol 28:626–630PubMedCrossRef Fioretti F, Tavani A, Gallus S et al (1999) Case-control study of thyroid cancer in Northern Italy: attributable risk. Int J Epidemiol 28:626–630PubMedCrossRef
6.
Zurück zum Zitat Bakiri F, Djemli FK, Mokrane LA et al (1998) The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer 82(6):1146–1153 Bakiri F, Djemli FK, Mokrane LA et al (1998) The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer 82(6):1146–1153
7.
Zurück zum Zitat Haghpanah V, Soliemanpour B, Heshmat R et al (2006) Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer 43(2):80–85PubMedCrossRef Haghpanah V, Soliemanpour B, Heshmat R et al (2006) Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer 43(2):80–85PubMedCrossRef
8.
Zurück zum Zitat LiVolsi VA, Baloch ZW (2004) Follicular neoplasm’s of the thyroid: view, biases, and experiences. Adv Anat Pathol 11(6):279–287PubMedCrossRef LiVolsi VA, Baloch ZW (2004) Follicular neoplasm’s of the thyroid: view, biases, and experiences. Adv Anat Pathol 11(6):279–287PubMedCrossRef
9.
Zurück zum Zitat Udelsman R, Westra WH, Donovan PI et al (2001) Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 233(5):716–722PubMedCrossRef Udelsman R, Westra WH, Donovan PI et al (2001) Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 233(5):716–722PubMedCrossRef
10.
Zurück zum Zitat Lin JD, Chao TC (2006) Follicular thyroid carcinoma: from diagnosis to treatment [review]. Endocr J 53(4):441–448. Epub 2006 Jun 27 Lin JD, Chao TC (2006) Follicular thyroid carcinoma: from diagnosis to treatment [review]. Endocr J 53(4):441–448. Epub 2006 Jun 27
11.
Zurück zum Zitat Chen H, Nicol TL, Udelsman R (1995) Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 222(1):101–106PubMedCrossRef Chen H, Nicol TL, Udelsman R (1995) Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 222(1):101–106PubMedCrossRef
12.
Zurück zum Zitat DeGroot LJ, Kaplan EL, Shukla MS et al (1995) Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 80(10):2946–2953PubMedCrossRef DeGroot LJ, Kaplan EL, Shukla MS et al (1995) Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 80(10):2946–2953PubMedCrossRef
13.
Zurück zum Zitat Passler C, Scheuba C, Asari R et al (2005) Importance of tumour size in papillary and follicular thyroid cancer. Br J Surg 92(2):184–189PubMedCrossRef Passler C, Scheuba C, Asari R et al (2005) Importance of tumour size in papillary and follicular thyroid cancer. Br J Surg 92(2):184–189PubMedCrossRef
14.
Zurück zum Zitat Lin JD, Liou MJ, Chao TC et al (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases [review]. Endocr Relat Cancer 6(1):109–115PubMedCrossRef Lin JD, Liou MJ, Chao TC et al (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases [review]. Endocr Relat Cancer 6(1):109–115PubMedCrossRef
15.
Zurück zum Zitat Ito Y, Miyauchi A (2007) Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31(5):905–915PubMedCrossRef Ito Y, Miyauchi A (2007) Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31(5):905–915PubMedCrossRef
16.
Zurück zum Zitat Miccoli P, Minuto MN, Ugolini C et al (2007) Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts. World J Surg 31(5):888–894PubMedCrossRef Miccoli P, Minuto MN, Ugolini C et al (2007) Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts. World J Surg 31(5):888–894PubMedCrossRef
17.
Zurück zum Zitat Jukkola A, Bloigu R, Ebeling T et al (2004) Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 11(3):571–579PubMedCrossRef Jukkola A, Bloigu R, Ebeling T et al (2004) Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 11(3):571–579PubMedCrossRef
18.
Zurück zum Zitat Loh KC, Greenspan FS, Gee L et al (1997) Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82(11):3553–3562PubMedCrossRef Loh KC, Greenspan FS, Gee L et al (1997) Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82(11):3553–3562PubMedCrossRef
19.
20.
Zurück zum Zitat Lang BH, Lo CY, Chan WF et al (2007) Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre [review]. Endocr Relat Cancer 14(1):29–42PubMedCrossRef Lang BH, Lo CY, Chan WF et al (2007) Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre [review]. Endocr Relat Cancer 14(1):29–42PubMedCrossRef
21.
Zurück zum Zitat White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer [review]. World J Surg 31(5):895–904PubMedCrossRef White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer [review]. World J Surg 31(5):895–904PubMedCrossRef
22.
Zurück zum Zitat Grebe SK, Hay ID (1996) Thyroid cancer nodal metastases: biologic significance and therapeutic considerations [review]. Surg Oncol Clin N Am 5(1):43–63PubMed Grebe SK, Hay ID (1996) Thyroid cancer nodal metastases: biologic significance and therapeutic considerations [review]. Surg Oncol Clin N Am 5(1):43–63PubMed
23.
Zurück zum Zitat Clark OH (1996) Predictors of thyroid tumor aggressiveness [review]. West J Med 165(3):131–138PubMed Clark OH (1996) Predictors of thyroid tumor aggressiveness [review]. West J Med 165(3):131–138PubMed
24.
Zurück zum Zitat Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154(6):787–803PubMedCrossRef Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154(6):787–803PubMedCrossRef
25.
Zurück zum Zitat Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106(3):524–531PubMedCrossRef Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106(3):524–531PubMedCrossRef
26.
Zurück zum Zitat Marchesi M, Biffoni M, Biancari F et al (2003) Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg Suppl 588:46–50PubMed Marchesi M, Biffoni M, Biancari F et al (2003) Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg Suppl 588:46–50PubMed
27.
Zurück zum Zitat Witte J, Goretzki PE, Dieken J et al (2002) Importance of lymph node metastases in follicular thyroid cancer. World J Surg 26:1017–1022. Epub 2002 Jun 6 Witte J, Goretzki PE, Dieken J et al (2002) Importance of lymph node metastases in follicular thyroid cancer. World J Surg 26:1017–1022. Epub 2002 Jun 6
28.
Zurück zum Zitat Simon D, Goretzki PE, Witte J et al (1996) Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20(7):860–866PubMedCrossRef Simon D, Goretzki PE, Witte J et al (1996) Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20(7):860–866PubMedCrossRef
29.
Zurück zum Zitat Cunha N, Rodrigues F, Curado F et al (2007) Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer. Eur J Endocrinol 157(1):101–107PubMedCrossRef Cunha N, Rodrigues F, Curado F et al (2007) Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer. Eur J Endocrinol 157(1):101–107PubMedCrossRef
Metadaten
Titel
Risk Factors for Lateral Cervical Lymph Node Involvement in Follicular Thyroid Carcinoma
verfasst von
Haitham Alfalah
Isaac Cranshaw
Thomas Jany
Laurent Arnalsteen
Emmanuelle Leteurtre
Catherine Cardot
François Pattou
Bruno Carnaille
Publikationsdatum
01.12.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 12/2008
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-008-9742-2

Weitere Artikel der Ausgabe 12/2008

World Journal of Surgery 12/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.